Aviso Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Buy
21,168
+6,490
+44% +$519K 0.05% 135
2025
Q4
$1.4M Buy
14,678
+529
+4% +$51.9K 0.05% 128
2025
Q3
$1.38M Sell
14,149
-752
-5% -$77.9K 0.06% 137
2025
Q2
$1.6M Sell
14,901
-1,540
-9% -$156K 0.07% 115
2025
Q1
$1.66M Sell
16,441
-606
-4% -$61K 0.08% 109
2024
Q4
$1.52M Sell
17,047
-6,093
-26% -$536K 0.08% 113
2024
Q3
$1.94M Sell
23,140
-1,014
-4% -$79.9K 0.1% 98
2024
Q2
$1.86M Buy
+24,154
New +$1.77M 0.1% 91

Other funds holding BSX

Aviso Financial's BSX Position: Q1 2026 in Review

Aviso Financial increased its Boston Scientific (BSX) stake by 44% in Q1 2026, buying an estimated $519K and bringing the position to 21,168 shares worth $1.33M. The position accounts for 0.05% of the portfolio, ranked #135.

Aviso Financial first reported a position in BSX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.94M in Q3 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Aviso Financial held 21,168 shares of Boston Scientific worth $1.33M as of Q1 2026.
  • Aviso Financial bought 6,490 Boston Scientific shares in Q1 2026, an estimated $519K.
  • Boston Scientific made up 0.05% of Aviso Financial's portfolio in Q1 2026, its #135 holding.
  • Aviso Financial first reported a position in Boston Scientific in Q2 2024 and has held it in 8 quarters since.
  • Aviso Financial's Boston Scientific position peaked at $1.94M in Q3 2024.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Aviso Financial's 13F filing for Q1 2026, filed 14 May 2026.